Abstract
AbstractHospital quality indicators provide valuable insights for quality improvement, empower patients to choose providers, and have become a cornerstone of value-based payment. As outcome indicators are cumbersome and expensive to measure, many health systems have relied on proxy indicators, such as structure and process indicators. In this paper, we assess the extent to which publicly reported structure and process indicators are correlated with outcome indicators, to determine if these provide useful signals to inform the public about the outcomes. Quality indicators for three conditions (breast and colorectal cancer, and hip replacement surgery) for Dutch hospitals (2011–2018) were collected. Structure and process indicators were compared to condition-specific outcome indicators and in-hospital mortality ratios in a between-hospital comparison (cross-sectional and between-effects models) and in within-hospital comparison (fixed-effects models). Systematic association could not be observed for any of the models. Both positive and negative signs were observed where negative associations were to be expected. Despite sufficient statistical power, the share of significant correlations was small [mean share: 13.2% (cross-sectional); 26.3% (between-effects); 13.2% (fixed-effects)]. These findings persisted in stratified analyses by type of hospital and in models using a multivariate approach. We conclude that, in the context of compulsory public reporting, structure and process indicators are not correlated with outcome indicators, neither in between-hospital comparisons nor in within-hospital comparisons. While structure and process indicators remain valuable for internal quality improvement, they are unsuitable as signals for informing the public about hospital differences in health outcomes.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference43 articles.
1. Donabedian, A.: The quality of care: how can it be assessed? JAMA 260(12), 1743–1748 (1988). https://doi.org/10.1001/jama.1988.03410120089033
2. Dranove, D.: Chapter ten—health care markets, regulators, and certifiers. In: Pauly, M.V., McGuire, T.G., Barros, P.P. (eds.) Handbook of Health Economics, vol. 2, pp. 639–690. Elsevier, Amsterdam (2011)
3. Southwell-Keely, J.P., Russo, R.R., March, L., Cumming, R., Cameron, I., Brnabic, A.J.M.: Antibiotic prophylaxis in hip fracture surgery: a meta analysis. Clin. Orthop. Relat. Res. (2004). https://doi.org/10.1097/01.blo.0000122663.98590.7b
4. Glenny, A., Song, F.: Antimicrobial prophylaxis in total hip replacement: a systematic review. Health Technol. Assess. (Winchester, England) 3(21), 1–57 (1999). https://doi.org/10.3310/hta3210
5. National Quality Forum (NQF): National voluntary consensus standards for patient outcomes: a consensus report. http://www.qualityforum.org/Publications/2011/07/National_Voluntary_Consensus_Standards_for_Patient_Outcomes_2009.aspx (2011). Accessed Apr 2021
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献